Full Text View
Tabular View
No Study Results Posted
Related Studies
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
This study has been completed.
Study NCT00355589   Information provided by Pfizer

First Received on July 20, 2006.   Last Updated on October 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Blood Pressure, High
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Ramipril and hydrochlorothiazide
Additional drug interventions recognized in this trial
Angiotensin-Converting Enzyme Inhibitors
Hydrochlorothiazide
Ramipril
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services